Similar articles

• [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].

  Veremeenko KN, Kizim AI. Veremeenko KN, et al. Vopr Med Khim. 1984 Sep-Oct;30(5):13-22. Vopr Med Khim. 1984. PMID: 6084892 Review. Russian.
• Thrombolytic therapy.

  Bailey A, Lydon JC, Spielman FJ. Bailey A, et al. Can Anaesth Soc J. 1985 Jul;32(4):385-9. doi: 10.1007/BF03011343. Can Anaesth Soc J. 1985. PMID: 4027765 No abstract available.
• Thrombolytic therapy.

  Kakkar VV, Scully MF. Kakkar VV, et al. Br Med Bull. 1978 May;34(2):191-9. doi: 10.1093/oxfordjournals.bmb.a071491. Br Med Bull. 1978. PMID: 148935 Review. No abstract available.
• [Acyl enzymes and pro-urokinase: promising new thrombolytic agents].

  Samama M, Horellou MH, Nguyen G, Conard J. Samama M, et al. Haemostasis. 1986;16 Suppl 4:35-9. doi: 10.1159/000215530. Haemostasis. 1986. PMID: 3095199 French. No abstract available.
• [Tissue plasminogen activator: mechanism of action and thrombolytic properties].

  Páramo JA, Collen D. Páramo JA, et al. Sangre (Barc). 1984;29(4-C):767-73. Sangre (Barc). 1984. PMID: 6393389 Review. Spanish. No abstract available.